Travere Therapeutics, Inc.
Travere Therapeutics, Inc. (TVTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
tvtx · stock forecast · 18 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 18 Wall Street analysts in the past 3 months
Buy
18 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$67.00
Consensus
$56.67
+20.4% upside
Low
$49.00
Median: $54 · Last Close: $47.08
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$56.67
20.4% upside
High Target
$67
42.3%
Low Target
$49
4.1%
Current Price
$47.08
as of today
Based on analyst price targets, the TVTX stock price prediction for the next 12 months ranges from $49 to $67. The consensus TVTX price forecast of $56.67 implies 20.4% upside from the current price of $47.08.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $47.71 | ↑ 1.34% |
1-day model range: $47.44–$47.98. Peak: $47.98 (+1.34%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $85 | +80.0% |
| 2028 | $125 | +166.4% |
| 2029 | $162 | +243.1% |
| 2030 | $189 | +302.4% |
| 2031 | — | +344.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TVTX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | Citigroup | Maintains | Buy→Buy |
| 2026-06-03 | Wedbush | Maintains | Outperform→Outperform |
| 2026-06-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-06 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-05-05 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-05 | Citigroup | Maintains | Buy→Buy |
| 2026-05-05 | TD Cowen | Maintains | Buy→Buy |
| 2026-05-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-24 | Guggenheim | Maintains | Buy→Buy |
| 2026-04-14 | Citigroup | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Travere Therapeutics, Inc. (TVTX) stock. Of the recent 132 rating actions, 4 were upgrades and 4 were downgrades. 18 analysts currently cover TVTX.
Analyst Recommendation Trends
TVTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$700M
↓ 40.8% YoY
Revenue Next Year
$970M
↑ 38.6% YoY
EPS This Year
$0.23
EPS Next Year
$2.52
↑ 985.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast TVTX EPS of $0.23 for the current fiscal year, based on estimates from 8 analysts. The TVTX revenue forecast is $700M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The TVTX stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TVTX price target is $56.67 (+20.4% upside), with an analyst consensus of Buy.
The TVTX short-term stock prediction for tomorrow is $47.71 (+1.34%). The TVTX stock price prediction for 2027 estimates an average of $85. The TVTX stock prediction for 2030 projects a range of $178–$201.
Travere Therapeutics, Inc. trades on NASDAQ under the ticker TVTX. The TVTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 83% of covering analysts.
Frequently asked questions
TVTX forecast · 8 questionsAccording to 18 Wall Street analysts, the average 12-month TVTX price target is $56.67, with a high forecast of $67.00 and a low of $49.00. The median price target is shown in the chart above when available. This implies +20.4% potential upside from the current price of $47.08.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.